灵康药业
(603669)
| 流通市值：36.57亿 | | | 总市值：36.57亿 |
| 流通股本：7.21亿 | | | 总股本：7.21亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 172,793,547 | 237,818,860.16 | 256,883,646.75 | 254,087,208.94 |
| 交易性金融资产 | 18,528,840.19 | 13,425,928.28 | 13,748,193.51 | 31,222,077.59 |
| 应收票据及应收账款 | 295,843,054.67 | 260,641,715.89 | 264,549,505.7 | 243,202,284.71 |
| 应收账款 | 295,843,054.67 | 260,641,715.89 | 264,549,505.7 | 243,202,284.71 |
| 应收款项融资 | 132,901.27 | - | - | - |
| 预付款项 | 13,713,156.9 | 1,442,382.57 | 1,502,751.79 | 17,934,665.05 |
| 其他应收款合计 | 3,143,341.39 | 3,169,380.91 | 4,890,203.2 | 4,692,354.82 |
| 存货 | 57,117,312.26 | 48,813,538.06 | 23,300,966.11 | 27,879,613.88 |
| 其他流动资产 | 13,998,857.46 | 7,227,842.14 | 9,785,871.31 | 7,592,358.81 |
| 流动资产合计 | 575,271,011.14 | 572,539,648.01 | 574,661,138.37 | 586,610,563.8 |
| 非流动资产: | | | | |
| 长期股权投资 | 13,637,789.6 | 13,895,241.98 | 14,584,608.81 | 17,939,111.32 |
| 其他权益工具投资 | 48,041,973.5 | 48,041,973.5 | 57,731,807.71 | 57,731,807.71 |
| 投资性房地产 | 6,709,631.13 | 6,813,003.89 | 6,916,376.64 | 7,024,151.54 |
| 固定资产 | 215,026,328.32 | 223,357,667.9 | 228,878,107.24 | 234,314,219.59 |
| 在建工程 | 228,223,631.76 | 228,223,631.76 | 228,223,631.76 | 228,223,631.76 |
| 使用权资产 | 5,735,830.17 | 6,200,897.49 | 6,665,964.81 | 7,131,032.13 |
| 无形资产 | 95,719,834.87 | 97,463,050.79 | 99,182,264.51 | 100,901,478.24 |
| 长期待摊费用 | 12,263,298.61 | 12,968,864.38 | 13,682,035.45 | 14,233,091.46 |
| 其他非流动资产 | 600,919 | 587,500 | 905,500 | 1,224,500 |
| 非流动资产合计 | 625,959,236.96 | 637,551,831.69 | 656,770,296.93 | 668,723,023.75 |
| 资产总计 | 1,201,230,248.1 | 1,210,091,479.7 | 1,231,431,435.3 | 1,255,333,587.55 |
| 流动负债: | | | | |
| 短期借款 | 5,000,000 | - | - | - |
| 应付票据及应付账款 | 103,831,518.5 | 157,453,873.07 | 116,250,867.7 | 109,561,545.54 |
| 其中：应付票据 | - | - | 14,086,726.1 | 16,031,280.1 |
| 应付账款 | 103,831,518.5 | 157,453,873.07 | 102,164,141.6 | 93,530,265.44 |
| 预收款项 | 100,037.8 | 298,352.63 | 332,755.75 | 198,758.68 |
| 合同负债 | 8,473,144.72 | 8,036,836.73 | 9,688,056.38 | 6,681,668.57 |
| 应付职工薪酬 | 2,250,093.95 | 2,426,791.82 | 2,715,592.09 | 8,205,429.32 |
| 应交税费 | 13,634,910.17 | 4,721,476.46 | 3,735,202.63 | 12,727,406.13 |
| 其他应付款合计 | 47,725,297.18 | 23,368,324.19 | 72,055,132.57 | 77,202,160.99 |
| 一年内到期的非流动负债 | 2,363,009.31 | 2,305,156.8 | 2,247,304.29 | 2,189,451.78 |
| 其他流动负债 | 1,614,251.49 | 1,407,144.81 | 2,185,183.32 | 2,547,790.54 |
| 流动负债合计 | 184,992,263.12 | 200,017,956.51 | 209,210,094.73 | 219,314,211.55 |
| 非流动负债: | | | | |
| 应付债券 | 273,206,191.54 | 268,099,847.26 | 262,994,537.52 | 257,991,407.31 |
| 租赁负债 | 4,074,716.22 | 4,074,716.22 | 4,074,716.22 | 4,074,716.22 |
| 递延收益 | 2,219,299.08 | 2,275,454.99 | 2,340,777.59 | 2,410,683.5 |
| 递延所得税负债 | 1,433,957.54 | 1,550,224.37 | 1,666,491.2 | 1,782,758.03 |
| 非流动负债合计 | 280,934,164.38 | 276,000,242.84 | 271,076,522.53 | 266,259,565.06 |
| 负债合计 | 465,926,427.5 | 476,018,199.35 | 480,286,617.26 | 485,573,776.61 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 721,244,755 | 721,244,755 | 721,244,755 | 721,244,005 |
| 其他权益工具 | 60,479,536.78 | 60,479,536.78 | 60,479,775.85 | 60,481,210.28 |
| 资本公积 | 262,693,656.05 | 262,693,656.05 | 262,652,509.36 | 262,645,577.37 |
| 减:库存股 | 110,019,822.2 | 110,019,822.2 | 110,019,822.2 | 110,019,822.2 |
| 其他综合收益 | -2,268,192.29 | -2,268,192.29 | -2,268,192.29 | -2,268,192.29 |
| 盈余公积 | 144,362,187.9 | 144,362,187.9 | 144,362,187.9 | 144,362,187.9 |
| 未分配利润 | -341,188,300.64 | -342,418,840.89 | -325,306,395.58 | -306,685,155.12 |
| 归属于母公司股东权益合计 | 735,303,820.6 | 734,073,280.35 | 751,144,818.04 | 769,759,810.94 |
| 股东权益合计 | 735,303,820.6 | 734,073,280.35 | 751,144,818.04 | 769,759,810.94 |
| 负债和股东权益合计 | 1,201,230,248.1 | 1,210,091,479.7 | 1,231,431,435.3 | 1,255,333,587.55 |
| 公告日期 | 2025-10-31 | 2025-08-23 | 2025-04-26 | 2025-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |